We are capable of storing a virtually infinite amount of visual information in visual long-term memory (VLTM) storage. At the same time, the amount of visual information we can encode and maintain in visual short-term memory (VSTM) at a given time is severely limited. How do these two memory systems interact to accumulate vast amount of VLTM? In this series of experiments, we exploited interindividual and intraindividual differences VSTM capacity to examine the direct involvement of VSTM in determining the encoding rate (or "bandwidth") of VLTM. Here, we found that the amount of visual information encoded into VSTM at a given moment (i.e., VSTM capacity), but neither the maintenance duration nor the test process, predicts the effective encoding "bandwidth" of VLTM.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823324 | PMC |
http://dx.doi.org/10.3758/s13421-019-00954-0 | DOI Listing |
J Lasers Med Sci
December 2024
Department of Periodontics, Dental Implants Research Center, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
Gingival depigmentation with the help of lasers is known as an effective technique. The aim of this study was to compare the efficiency of 980nm diode and CO2 lasers in the treatment of gingival hyperpigmentation. In this clinical trial study, 14 individuals (8 females and 6 males) with the age range of 19 to 47 years were selected.
View Article and Find Full Text PDFAm J Ophthalmol Case Rep
December 2024
Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, FL, USA.
Femtosecond laser-assisted cataract surgery (FLACS) is a useful technology for anterior segment surgery that creates cleavage planes via photodisruption of ocular tissue. Compared to conventional cataract surgery, FLACS has been thought to potentially improve surgical precision, accuracy, and reproducibility. Its introduction into cataract surgery has enabled the development of new techniques and has been purported to be potentially beneficial in improving surgical safety and providing quicker visual rehabilitation.
View Article and Find Full Text PDFNat Sci Sleep
January 2025
Department of Anesthesiology, Hospital for Skin Diseases (Institute of Dermatology), Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, 210042, People's Republic of China.
Purpose: The aim of this study was to investigate the effect of general anesthesia combined with transversus abdominis plane block on postoperative sleep disorders in elderly patients undergoing gastrointestinal tumor surgery.
Methods: For elderly patients with gastrointestinal malignant tumors, we recruited 94 patients, aged 65-80, who were scheduled for radical laparoscopic surgery. Using the random number table method, the patients were randomly divided into two groups, the general anesthesia group (group GA) and the general anesthesia combined with transversus abdominis plane block group (group GT).
Int J Lang Commun Disord
January 2025
Department of Language and Cognition, University College London, London, UK.
Background: Global aphasia is a severe communication disorder affecting all language modalities, commonly caused by stroke. Evidence as to whether the functional communication of people with global aphasia (PwGA) can improve after speech and language therapy (SLT) is limited and conflicting. This is partly because cognition, which is relevant to participation in therapy and implicated in successful functional communication, can be severely impaired in global aphasia.
View Article and Find Full Text PDFJ Clin Med
December 2024
Division of Ophthalmology, Department of Surgery, UMass Chan-Lahey School of Medicine, Burlington, MA 01805, USA.
Personalizing the management of neovascular age-related macular degeneration (nAMD) poses significant challenges for practicing retina specialists and their patients. This commentary addresses some of these complexities, particularly those that arise in the context of an expanding array of intravitreal agents targeting vascular endothelial growth factor (VEGF) and related retinal disease targets. Many of these newer agents approved by the Food and Drug Administration (FDA) for the treatment of nAMD have labeling that indicates that they can provide non-inferior visual outcomes when compared head-to-head with previously available treatments and can be used at significantly extended dosing intervals in some patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!